Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy
20. Februar 2025 12:00 ET
|
Neurona Therapeutics
Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy
Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
20. Februar 2025 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
YPrime Releases Reimagined eCOA Automated Data Change Form for More Efficient Clinical Trial Data Management
04. Februar 2025 08:00 ET
|
Y-Prime, LLC
YPrime launches eCOA Automated Data Change Form, reimagining clinical trial data management with enhanced efficiency and accuracy.
Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
30. Januar 2025 08:00 ET
|
Jupiter Neurosciences, Inc.
Jupiter, Florida, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented...
[Latest] Global Clinical Trial Outsourcing Market Size/Share Worth USD 91,210.1 Million by 2033 at a 7.46% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
15. Januar 2025 08:10 ET
|
Custom Market Insights
Austin, TX, USA, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Clinical Trial Outsourcing Market Size, Trends and Insights By Services...
YPrime’s Karl McEvoy Appointed as eCOA Consortium Industry Co-Director for 2025
14. Januar 2025 08:00 ET
|
Y-Prime, LLC
YPrime's Dr. Karl McEvoy, VP eCOA & Patient Technologies, has been appointed Industry Co-Director of the Critical Path Institute (C-Path) eCOA Consortium
Franklin Access (Formerly Franklin Wireless) Successfully Defends Shareholder Litigation
24. Dezember 2024 13:00 ET
|
Franklin Wireless Corporation
SAN DIEGO, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Franklin Access is pleased to announce a significant legal victory in its shareholder litigation, “In re Franklin Wireless Corp. Derivative Litigation”,...
BIOA BREAKING NEWS: BFA Law Announces an Investigation into BioAge Labs, Inc. after Stock Plummets 76% -- Contact the Firm if You Lost Money (NASDAQ:BIOA)
10. Dezember 2024 12:49 ET
|
Bleichmar Fonti & Auld
BioAge Labs, Inc. investors that lost money are encouraged to contact BFA Law about its securities fraud investigation into the Company.
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
19. November 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Legendary Attorney Glenn Zeitz Launches Podcast: Philly Trial Lawyer Stories
24. Oktober 2024 10:00 ET
|
Glenn Zeitz
PHILADELPHIA, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Philly Trial Lawyer Stories, a new podcast from legendary attorney Glenn Zeitz, is set to launch on October 23rd offering listeners an exclusive,...